Profile data is unavailable for this security.
About the company
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.
- Revenue in USD (TTM)3.56bn
- Net income in USD942.00m
- Incorporated2000
- Employees7.70k
- LocationIllumina Inc5200 Illumina WaySAN DIEGO 92122-4616United StatesUSA
- Phone+1 (858) 202-4500
- Fax+1 (858) 202-4766
- Websitehttps://www.illumina.com
More ▼
Mergers & acquisitions
| Acquired company | ILMN:NSQ since announced | Transaction value |
|---|---|---|
| Bluebee Holding BV | 5.97% | -- |
Data delayed at least 15 minutes, as of Jul 14 2020 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PerkinElmer, Inc. | 2.89bn | 226.02m | 11.64bn | 13.00k | 51.23 | 4.21 | 25.85 | 4.03 | 2.04 | 2.04 | 26.03 | 24.79 | 0.463 | 3.87 | 4.62 | 222,102.50 | 3.62 | 4.38 | 4.11 | 5.08 | 48.36 | 47.69 | 7.83 | 9.32 | 1.30 | 6.15 | 0.4226 | 13.70 | 3.80 | 5.21 | -3.27 | 7.16 | 24.53 | 0.00 |
| Waters Corporation | 2.36bn | 536.77m | 11.97bn | 7.50k | 23.76 | -- | 18.52 | 5.07 | 8.13 | 8.13 | 35.86 | -5.46 | 0.797 | 2.95 | 4.58 | 314,356.40 | 18.15 | 12.95 | 22.54 | 14.86 | 57.57 | 58.87 | 22.77 | 24.20 | 1.79 | 19.66 | 1.22 | 0.00 | -0.551 | 3.88 | -1.05 | 6.41 | 9.05 | -- |
| Bio-Rad Laboratories, Inc. | 2.33bn | 1.58bn | 13.72bn | 8.12k | 8.97 | 2.20 | 8.00 | 5.89 | 52.17 | 52.17 | 77.34 | 212.27 | 0.2996 | 1.85 | 6.03 | 286,862.60 | 20.32 | 9.80 | 22.19 | 11.02 | 54.34 | 54.77 | 67.80 | 20.89 | 1.76 | -- | 0.0651 | 0.00 | 0.9716 | 1.23 | 455.46 | 81.68 | -4.02 | -- |
| Keysight Technologies Inc | 4.20bn | 585.00m | 17.73bn | 13.70k | 30.90 | 5.73 | 19.67 | 4.22 | 3.07 | 3.08 | 22.03 | 16.54 | 0.6483 | 2.43 | 7.33 | 308,602.90 | 9.04 | 7.26 | 11.13 | 8.95 | 59.07 | 55.72 | 13.94 | 10.13 | 2.67 | 11.73 | 0.3669 | 0.00 | 10.96 | 7.97 | 276.36 | 9.64 | 11.38 | -- |
| Mettler-Toledo International Inc. | 2.98bn | 547.42m | 19.70bn | 16.20k | 37.23 | 64.29 | 30.87 | 6.61 | 22.13 | 22.13 | 120.41 | 12.82 | 1.08 | 4.36 | 5.91 | 183,849.50 | 19.83 | 19.35 | 26.48 | 26.91 | 58.00 | 57.40 | 18.38 | 16.67 | 1.34 | 18.91 | 0.8367 | 0.00 | 2.49 | 3.89 | 8.70 | 10.65 | 1.72 | -- |
| AMETEK, Inc. | 5.07bn | 937.65m | 20.30bn | 18.10k | 21.70 | 3.81 | 17.20 | 4.00 | 4.08 | 4.08 | 22.06 | 23.21 | 0.5205 | 5.10 | 6.22 | 280,280.90 | 9.62 | 8.66 | 11.03 | 10.12 | 34.94 | 36.76 | 18.48 | 15.01 | 1.43 | 13.21 | 0.3792 | 15.31 | 6.45 | 5.10 | 12.42 | 8.06 | 7.49 | 11.16 |
| Fortive Corp | 7.44bn | 534.70m | 22.78bn | 25.00k | 43.02 | 3.15 | 22.86 | 3.06 | 1.57 | 1.61 | 21.88 | 21.50 | 0.4567 | 5.87 | 6.04 | 297,624.00 | 3.71 | 7.91 | 4.34 | 9.60 | 50.31 | 50.23 | 8.11 | 13.03 | 1.32 | 5.43 | 0.4558 | 8.52 | 13.44 | 2.93 | -24.59 | -5.77 | 1.86 | -- |
| Agilent Technologies Inc | 5.24bn | 683.00m | 27.56bn | 16.37k | 40.96 | 5.77 | 28.44 | 5.26 | 2.18 | 2.18 | 16.72 | 15.48 | 0.5668 | 3.45 | 6.14 | 321,227.00 | 7.39 | 8.31 | 8.86 | 9.75 | 53.67 | 53.17 | 13.04 | 15.46 | 1.24 | 18.26 | 0.3429 | 24.13 | 5.07 | 4.99 | 23.39 | 35.79 | -5.32 | 4.43 |
| Emerson Electric Co. | 17.97bn | 2.26bn | 36.34bn | 88.00k | 16.55 | 4.84 | 11.62 | 2.02 | 3.68 | 3.51 | 29.20 | 12.58 | 0.8401 | 5.00 | 5.73 | 204,215.90 | 10.70 | 9.61 | 16.33 | 14.23 | 42.57 | 42.59 | 12.74 | 12.46 | 0.7524 | 18.52 | 0.5045 | 61.30 | 5.54 | 0.7105 | 14.50 | 0.9364 | -1.82 | 2.65 |
| Illumina, Inc. | 3.56bn | 942.00m | 54.26bn | 7.70k | 58.22 | 11.71 | 48.28 | 15.26 | 6.34 | 6.34 | 23.95 | 31.53 | 0.4854 | 2.65 | 7.66 | 461,818.20 | 12.82 | 13.71 | 15.35 | 17.11 | 70.36 | 68.98 | 26.41 | 24.54 | 3.74 | -- | 0.1989 | 0.00 | 6.30 | 13.74 | 19.71 | 23.18 | 8.00 | -- |
| Danaher Corporation | 17.37bn | 2.61bn | 129.14bn | 60.00k | 50.30 | 4.32 | 34.24 | 7.43 | 3.63 | 4.43 | 24.12 | 44.56 | 0.2879 | 3.33 | 4.92 | 289,571.70 | 4.46 | 4.59 | 5.01 | 5.21 | 55.88 | 55.29 | 15.50 | 13.33 | 1.01 | -- | 0.4553 | 19.31 | 5.06 | 6.84 | -1.48 | 7.60 | 6.43 | 15.57 |
Data as of Jul 14 2020. Currency figures normalised to Illumina Inc's reporting currency: US Dollar USD
42.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 31 Mar 2020 | 17.62m | 11.99% |
| The Vanguard Group, Inc.as of 31 Mar 2020 | 11.03m | 7.50% |
| BlackRock Fund Advisorsas of 31 Mar 2020 | 7.75m | 5.27% |
| SSgA Funds Management, Inc.as of 31 Mar 2020 | 6.09m | 4.14% |
| Edgewood Management LLCas of 31 Mar 2020 | 4.86m | 3.31% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2020 | 4.21m | 2.87% |
| Sands Capital Management LLCas of 31 Mar 2020 | 3.26m | 2.22% |
| Morgan Stanley Investment Management, Inc.as of 31 Mar 2020 | 2.54m | 1.73% |
| Geode Capital Management LLCas of 31 Mar 2020 | 2.43m | 1.66% |
| Norges Bank Investment Managementas of 31 Dec 2019 | 1.95m | 1.33% |
More ▼
Data from 31 Dec 2019 - 31 Mar 2020Source: FactSet Research Systems Inc.
